These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22566103)

  • 1. Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment.
    Saleh N; Petursson P; Lagerqvist B; Skúladóttir H; Svensson A; Eliasson B; Gudbjörnsdottir S; Eeg-Olofsson K; Norhammar A
    Diabetologia; 2012 Aug; 55(8):2109-17. PubMed ID: 22566103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study.
    Horsdal HT; Johnsen SP; Søndergaard F; Rungby J
    Diabetologia; 2008 Apr; 51(4):567-74. PubMed ID: 18283428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Diabetologia; 2011 Jun; 54(6):1308-17. PubMed ID: 21359582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
    Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A;
    Eur Heart J; 2005 Apr; 26(7):650-61. PubMed ID: 15728645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.
    Fisman EZ; Tenenbaum A; Benderly M; Goldbourt U; Behar S; Motro M
    Cardiology; 1999; 91(3):195-202. PubMed ID: 10516414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-treated diabetes mellitus and predictors of mid-term clinical outcome after percutaneous coronary interventions with stent implantation.
    Tarantini G; Briguori C; Stankovic G; Takagi T; Corvaja N; Di Mario C; Colombo A
    Ital Heart J; 2003 Dec; 4(12):843-9. PubMed ID: 14976848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project).
    Berger AK; Breall JA; Gersh BJ; Johnson AE; Oetgen WJ; Marciniak TA; Schulman KA
    Am J Cardiol; 2001 Feb; 87(3):272-7. PubMed ID: 11165959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up.
    Fisman EZ; Tenenbaum A; Boyko V; Benderly M; Adler Y; Friedensohn A; Kohanovski M; Rotzak R; Schneider H; Behar S; Motro M
    Clin Cardiol; 2001 Feb; 24(2):151-8. PubMed ID: 11460818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment modalities of diabetes mellitus and outcomes of acute coronary syndromes.
    Hasdai D; Behar S; Boyko V; Battler A
    Coron Artery Dis; 2004 May; 15(3):129-35. PubMed ID: 15096993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome.
    Natali A; Vichi S; Landi P; Severi S; L'Abbate A; Ferrannini E
    Diabetologia; 2000 May; 43(5):632-41. PubMed ID: 10855538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
    Ekström N; Svensson AM; Miftaraj M; Franzén S; Zethelius B; Eliasson B; Gudbjörnsdottir S
    Diabetes Obes Metab; 2016 Oct; 18(10):990-8. PubMed ID: 27282621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Satisfaction with glucose-lowering treatment and well-being in patients with type 2 diabetes and myocardial infarction: a DIGAMI2 QoL sub-study.
    Venskutonyte L; Brismar K; Rydén-Bergsten T; Rydén L; Kjellström B
    Diab Vasc Dis Res; 2013 May; 10(3):263-9. PubMed ID: 23188892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study.
    Schofer J; Schlüter M; Rau T; Hammer F; Haag N; Mathey DG
    J Am Coll Cardiol; 2000 May; 35(6):1554-9. PubMed ID: 10807460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Waldenström A; Wedel H; Rydén L;
    Heart; 2009 May; 95(9):721-7. PubMed ID: 19029171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival.
    Currie CJ; Holden SE; Jenkins-Jones S; Morgan CL; Voss B; Rajpathak SN; Alemayehu B; Peters JR; Engel SS
    Diabetes Obes Metab; 2018 Apr; 20(4):821-830. PubMed ID: 29119713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
    Kress S; Kostev K; Dippel FW; Giani G; Rathmann W
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus: results from the Swedish coronary angiography and angioplasty registry.
    Ritsinger V; Saleh N; Lagerqvist B; Norhammar A
    Circ Cardiovasc Interv; 2015 Jun; 8(6):e002328. PubMed ID: 26025219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery.
    Kogan A; Ram E; Levin S; Fisman EZ; Tenenbaum A; Raanani E; Sternik L
    Cardiovasc Diabetol; 2018 Nov; 17(1):151. PubMed ID: 30497472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.